Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalMarket Capitalization

RedHill Biopharma (RDHL) Return on Assets: 2013-2023

Historic Return on Assets for RedHill Biopharma (RDHL) over the last 10 years, with Jun 2023 value amounting to -0.85%.

  • RedHill Biopharma's Return on Assets rose 13.00% to -0.85% in Q2 2023 from the same period last year, while for Jun 2023 it was -0.85%, marking a year-over-year increase of 13.00%. This contributed to the annual value of -0.40% for FY2024, which is 67.00% down from last year.
  • Per RedHill Biopharma's latest filing, its Return on Assets stood at -0.85% for Q2 2023, which was up 35.52% from -1.32% recorded in Q1 2023.
  • In the past 5 years, RedHill Biopharma's Return on Assets registered a high of 0.99% during Q3 2019, and its lowest value of -1.32% during Q1 2023.
  • In the last 3 years, RedHill Biopharma's Return on Assets had a median value of -0.67% in 2022 and averaged -0.51%.
  • Its Return on Assets has fluctuated over the past 5 years, first rose by 16bps in 2021, then crashed by 167bps in 2022.
  • Over the past 5 years, RedHill Biopharma's Return on Assets (Quarterly) stood at 0.77% in 2019, then crashed by 34bps to 0.43% in 2020, then crashed by 96bps to -0.53% in 2021, then dropped by 25bps to -0.78% in 2022, then climbed by 13bps to -0.85% in 2023.
  • Its Return on Assets was -0.85% in Q2 2023, compared to -1.32% in Q1 2023 and -0.78% in Q4 2022.